• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care
Prostate Cancer : Episode 2

Episode 2 - Immunotherapy in CRPC

Video

During this segment, David Crawford, MD, discusses immunotherapy’s role in castration-resistant prostate cancer (CRPC), and explains how the US Food and Drug Administration’s approval of sipuleucel-T has led to a paradigm shift in the way that CRPC is treated.

Dr Crawford explains the unique capabilities of immunotherapy for advanced disease when compared to conventional treatment options such as cytotoxic chemotherapy.

Additionally, David Quinn, MD, discusses hormonal therapy agents, the key clinical trials that have tested these treatment options, and explains how the trials have demonstrated improved outcomes in CRPC.

Related Videos
Dr Jennifer Graff, Dr Joey Mattinly, and Brian Reid Dr Jennifer Graff and Brian Reid | Background image credit: ipopba - stock.adobe.com
Drs Yelena Janjigian and Zev Wainberg | Background image credit: ipopba - stock.adobe.com
Dr Jennifer Graff and Brian Reid | Background image credit: ipopba - stock.adobe.com
Nicoletta Colombo, MD, PhD
Eleanor Perfetto, PhD
Jonathan Strober, MD, Benioff Children's Hospital
Ciara Zachary, PhD, MPH
Related Content
Girl Brushing Teeth | Image credit: MIA Studios - stock.adobe.com

5 Things Driving Better Dental Health Access in Underserved Communities

December 5th 2025
Article

Public health dental hygienists expand dental care access and oral health education in underserved communities, improving overall health outcomes.

Read More

Managed Care Cast

Frameworks for Advancing Health Equity: Dental Health Care Access

December 2nd 2025
Podcast

Explore innovative strategies in dental care that are enhancing access, promoting health equity, and improving community health in Pennsylvania.

Listen

Insurance options | Image credit: Rawpixel.com

Most Americans Pleased With Health Insurance Options for 2026

December 4th 2025
Article

As open enrollment continues, 77% of surveyed Americans were happy with their options for 2026 health care coverage, although cost concerns surfaced.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

November 25th 2025
Podcast

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

AJMC original research policy

Trends in Hospital Pricing for Vulnerable Emergency Department Users, 2021-2023

December 4th 2025
Article

Self-pay emergency department prices rose significantly from 2021 to 2023, especially at for-profit and system-affiliated hospitals, highlighting growing affordability challenges for uninsured and underinsured patients.

Read More

How expiring ACA subsidies could reshape coverage choices for employees and employers. | Image credit: @iQoncept-stock.adobe.com.jpeg

What ACA Subsidy Expiration Means for Coverage Costs, Employer Strategy, and ICHRAs: Q&A With Ben Light

December 2nd 2025
Article

With ACA subsidies ending in 2025, Ben Light explains how rising premiums may push individuals toward ICHRAs and reshape employer health coverage strategy.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.